SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001626129-16-000824
Filing Date
2016-09-12
Accepted
2016-09-12 17:04:40
Documents
1
Period of Report
2016-10-13

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT mtnb-pre14a_101316.htm PRE 14A 368360
  Complete submission text file 0001626129-16-000824.txt   369401
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 333-193455 | Film No.: 161881472
SIC: 2834 Pharmaceutical Preparations